Sage Therapeutics Launches SageCitizen Social Impact Initiative
October 01 2021 - 5:30AM
Business Wire
Effort embodies Sage’s long-term commitment to
investing in People, Patients, Planet and Community
Sage Therapeutics (Nasdaq: SAGE), a biopharmaceutical company
committed to developing novel therapies with the potential to
transform the lives of people with debilitating disorders of the
brain, today announced the launch of SageCitizen – a corporate
social impact effort that activates and amplifies Sage’s long-term
commitment to People, Patients, Planet and Community.
“At the core of our work at Sage is our mission to transform the
lives of people with brain health disorders. We see the potential
positive impact we can have on individuals, families and society
not just with the novel treatments that we are developing, but with
our engagement in the communities where we live and work,” said
Barry Greene, Chief Executive Officer at Sage Therapeutics. “In the
context of the current brain health pandemic, the launch of
SageCitizen solidifies our deep, long-term relationships with
community partners in a strategic and holistic way that aligns with
our goal of making a meaningful and sustained contribution to
people and society.”
SageCitizen launched with more than 200 Sage employee volunteers
participating in a week of service comprised of virtual and
in-person activities, including:
- Packing Emergency Aid duffle bags with longtime partner
Wonderfund, a private, non-profit organization that works on behalf
of children engaged with the Massachusetts Department of Children
and Families. Sage volunteers assembled close to 500 bags with new
clothing and essential items for children who experience emergency
home removals due to abuse and neglect.
- Building beds with Boston Cares, New England’s largest
volunteer agency, Sage volunteers worked in teams to sand,
assemble, and paint twin bed frames for homeless children,
providing them access to their own beds when transitioning from
shelters to new residencies through the Massachusetts Coalition for
the Homeless – A Bed for Every Child Initiative.
- Packaging a one-month supply of menstrual products with Dignity
Matters, a non-profit organization that collects, purchases, and
supplies feminine hygiene products and undergarments to low-income
and homeless women and girls in the Boston area. The packages will
help them stay healthy, regain self-confidence, and live with basic
dignity. Sage employees also wrote letters of support and
affirmation to recipients of the hygiene packages.
SageCitizen formalizes Sage’s social impact efforts, further
strengthening the social impact of the philanthropic and community
activities Sage and its employees have been involved in since 2014.
SageCitizen is organized around four pillars:
- People – Sage is committed to providing employees a
meaningful career journey and an inclusive culture where they can
do their best work, while channeling their passion for helping
others with opportunities to make a difference and improve lives.
Sage celebrates people for who they are through a culture of
respect and belonging that welcomes fresh thinking and unique
perspectives. The company’s holistic well-being benefits and
SageFlex work model support Sage employees to live life to its
fullest, whether in the office, their homes, or their
communities.
- Patients – Partnering with and learning from diverse
patient organizations is core to Sage’s mission to make medicines
that matter so people can get better sooner. These groups serve a
vital role as independent patient champions and agents of change in
pursuit of several shared goals: reducing stigma, improving patient
care, and enhancing access to medicines and services for people
impacted by brain health disorders.
- Planet – Recognizing that no one company can solve the
planet’s problems alone, Sage is committed to doing its part to
reduce its carbon footprint and make the earth a healthier place to
live. Sage provides green transportation incentives, reduces its
waste stream by composting, recycling and eliminating plastic, and
educates Sage employees about how to integrate green best practices
at home.
- Community – Sage engages with organizations supporting
families, children and individuals who are facing hardship or
social isolation that can lead to depression. Sage’s community
philanthropy focus areas are essential service organizations that
supplement daily necessities from food to clothing to temporary
shelter; and social connection programs that increase connectivity
for those separated from loved ones, letting them know they are not
alone and that someone cares.
Through SageCitizen, Sage seeks to deepen relationships with its
partners by developing more long-term engagement opportunities that
are intended to increase impact on the well-being of Sage’s people,
patients, planet, and communities where they work and live.
“Putting people first is part of everything we do at Sage – from
how we engage and treat patients and their families, to the respect
and compassion we have for each other, our community and our
planet,” said Erin Lanciani, Chief People & Experience Officer,
Sage Therapeutics. “We are thrilled to formalize these efforts as
we launch SageCitizen.”
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to
developing novel therapies with the potential to transform the
lives of people with debilitating disorders of the brain. We are
pursuing new pathways with the goal of improving brain health and
our depression, neurology and neuropsychiatry franchise programs
aim to change how brain disorders are thought about and treated.
Our mission is to make medicines that matter so people can get
better, sooner. For more information, please visit
www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211001005134/en/
Investor Contact Helen Rubinstein 315-382-3979
helen.rubinstein@sagerx.com
Media Contact Maureen L. Suda 617-949-4289
maureen.suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Oct 2023 to Oct 2024